Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIFAMPIN Cause Contraindicated product administered? 22 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Contraindicated product administered have been filed in association with RIFAMPIN (Rifampin). This represents 0.2% of all adverse event reports for RIFAMPIN.

22
Reports of Contraindicated product administered with RIFAMPIN
0.2%
of all RIFAMPIN reports
0
Deaths
11
Hospitalizations

How Dangerous Is Contraindicated product administered From RIFAMPIN?

Of the 22 reports, 11 (50.0%) required hospitalization, and 1 (4.5%) were considered life-threatening.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIFAMPIN. However, 22 reports have been filed with the FAERS database.

What Other Side Effects Does RIFAMPIN Cause?

Drug ineffective (1,238) Drug reaction with eosinophilia and systemic symptoms (1,049) Drug interaction (735) Pyrexia (735) Acute kidney injury (684) Drug-induced liver injury (684) Off label use (640) Condition aggravated (597) Nausea (572) Paradoxical drug reaction (570)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which RIFAMPIN Alternatives Have Lower Contraindicated product administered Risk?

RIFAMPIN vs RIFAMYCIN RIFAMPIN vs RIFAPENTINE RIFAMPIN vs RIFAXIMIN RIFAMPIN vs RILMENIDINE RIFAMPIN vs RILONACEPT

Related Pages

RIFAMPIN Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered RIFAMPIN Demographics